| P2093 | author name string | Martin M Brown | |
| | Geoffrey Keir | |
| | Pooja Dassan | |
| | Hans Rolf Jäger | |
| P2860 | cites work | Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment | Q22306370 |
| | Ethanol stimulates tumor progression and expression of vascular endothelial growth factor in chick embryos | Q28298208 |
| | The biology of vascular endothelial growth factor | Q29615946 |
| | Tissue plasminogen activator for acute ischemic stroke | Q29619377 |
| | Comparison of MRI and CT for detection of acute intracerebral hemorrhage | Q34360419 |
| | Angiogenesis in ischemic and neoplastic disorders | Q34931041 |
| | Blood biomarkers in the diagnosis of ischemic stroke: a systematic review | Q37227913 |
| | Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke | Q40754122 |
| | Patient delay in acute stroke response | Q43135255 |
| | Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes | Q47420220 |
| | VEGF-mediated inflammation precedes angiogenesis in adult brain | Q47601994 |
| | Is visible infarction on computed tomography associated with an adverse prognosis in acute ischemic stroke? | Q48433042 |
| | Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis | Q48545238 |
| P433 | issue | 6 | |
| P304 | page(s) | 454-459 | |
| P577 | publication date | 2011-11-22 | |
| P1433 | published in | International Journal of Stroke | Q15763625 |
| P1476 | title | Value of measuring serum vascular endothelial growth factor levels in diagnosing acute ischemic stroke. | |
| P478 | volume | 7 | |